I agree that this site is using cookies. You can find further informations here.
X
Bodoky, György
84  results:
Search for persons X
?
1

A hepatocellularis carcinoma komplex kezelése.: Konszenzusk..:

_, _ ; Hahn, Oszkár ; Szijártó, Attila...
Orvosi Hetilap.  162 (2022)  Supplement-2 - p. 2-31 , 2022
Link: https://doi.org/10.1556/..
 
?
2

Rationale and Design of the PROMETCO Study: A Real-World, P..:

Koopman, Miriam ; Pinto, Carmine ; Bodoky, György...
Future Oncology.  18 (2022)  11 - p. 1313-1320 , 2022
Link: https://doi.org/10.2217/..
 
?
3

Tumor Response and Symptom Palliation from RAINBOW, a Phase..:

Cascinu, Stefano ; Bodoky, György ; Muro, Kei...
The Oncologist.  26 (2020)  3 - p. e414-e424 , 2020
Link: https://doi.org/10.1002/..
 
?
4

Current therapy of advanced colorectal cancer according to ..:

Lakatos, Gábor ; Köhne, Claus-Henning ; Bodoky, György
Cancer and Metastasis Reviews.  39 (2020)  4 - p. 1143-1157 , 2020
Link: https://doi.org/10.1007/..
 
?
5

ESMO Clinical Research Observatory (ECRO): improving the ef..:

Perez-Gracia, Jose Luis ; Awada, Ahmad ; Calvo, Emiliano...
ESMO Open.  5 (2020)  3 - p. e000662 , 2020
Link: https://doi.org/10.1136/..
 
?
6

Survival Benefits of Second-line Axitinib Versus Everolimus..:

Géczi, Lajos ; Bodoky, György ; Rokszin, György..
Pathology & Oncology Research.  26 (2020)  4 - p. 2201-2207 , 2020
Link: https://doi.org/10.1007/..
 
?
7

Predicting mortality and adverse events in patients with ad..:

Gargiulo, Piera ; Dietrich, Daniel ; Herrmann, Richard...
Therapeutic Advances in Medical Oncology.  11 (2019)  - p. 175883591881835 , 2019
Link: https://doi.org/10.1177/..
 
?
8

Association of baseline absolute neutrophil counts and surv..:

Grothey, Axel ; Yoshino, Takayuki ; Bodoky, Gyorgy...
ESMO Open.  3 (2018)  3 - p. e000347 , 2018
Link: https://doi.org/10.1136/..
 
?
9

4:12 PM Abstract No. 379 Updated overall survival (OS) anal..:

Han, Guohong ; Merle, Philippe ; Granito, Alessandro...
Journal of Vascular and Interventional Radiology.  29 (2018)  4 - p. S162-S163 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Expenditures on Oncology Drugs and Cancer Mortality-to-Inci..:

Vrdoljak, Eduard ; Bodoky, Gyorgy ; Jassem, Jacek...
The Oncologist.  24 (2018)  1 - p. e30-e37 , 2018
Link: https://doi.org/10.1634/..
 
?
11

Neoadjuvant radiotherapy combined with capecitabine and sor..:

von Moos, Roger ; Koeberle, Dieter ; Schacher, Sabina...
European Journal of Cancer.  89 (2018)  - p. 82-89 , 2018
Link: https://doi.org/10.1016/..
 
?
12

Survival with nal-IRI (liposomal irinotecan) plus 5-fluorou..:

Chen, Li-Tzong ; Siveke, Jens T. ; Wang-Gillam, Andrea...
European Journal of Cancer.  105 (2018)  - p. 71-78 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Outcomes of sequential treatment with sorafenib followed by..:

Finn, Richard S. ; Merle, Philippe ; Granito, Alessandro...
Journal of Hepatology.  69 (2018)  2 - p. 353-358 , 2018
Link: https://doi.org/10.1016/..
 
?
14

Age does not influence efficacy of ramucirumab in advanced ..:

Muro, Kei ; Cho, Jae Yong ; Bodoky, Gyorgy...
Journal of Gastroenterology and Hepatology.  33 (2018)  4 - p. 814-824 , 2018
Link: https://doi.org/10.1111/..
 
?
15

Consensus statement on essential patient characteristics in..:

Goey, Kaitlyn K.H. ; Sørbye, Halfdan ; Glimelius, Bengt...
European Journal of Cancer.  100 (2018)  - p. 35-45 , 2018
Link: https://doi.org/10.1016/..
 
1-15